← Back to Search

Crisis Response Planning for Suicide Prevention

N/A
Recruiting
Led By Stephanie Gorka, PhD
Research Sponsored by Ohio State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 18 years or older at the time of consent
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre-treatment, post-treatment, 1-week post-intervention, monthly post-intervention, and 6-months post-intervention.
Awards & highlights

Study Summary

This trial is testing whether a one-hour session of crisis response planning (CRP) can help reduce suicide risk in adults, compared to a one-hour session of standard crisis risk management (Treatment as Usual).

Who is the study for?
Adults with current suicidal intent, as indicated by a score of 5 or more on the Beck's Scale for Suicidal Ideation. Participants must be generally healthy and able to give informed consent. Excluded are those with certain mental health conditions, pregnant women, individuals under drug influence during scans, people uncomfortable in small spaces, non-English speakers, and anyone with metal implants.Check my eligibility
What is being tested?
The study compares two suicide prevention strategies: a one-hour session of Crisis Response Planning (CRP) versus standard crisis risk management. The impact on emotion regulation and suicide risk is assessed immediately after and six months post-intervention. Daily mood checks occur for the first ten days then monthly up to six months.See study design
What are the potential side effects?
Since this trial involves counseling interventions rather than medications or medical procedures, traditional side effects are not applicable. However, participants may experience emotional discomfort discussing sensitive topics like suicidality.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre-treatment, post-treatment, 1-week post-intervention, monthly post-intervention, and 6-months post-intervention.
This trial's timeline: 3 weeks for screening, Varies for treatment, and pre-treatment, post-treatment, 1-week post-intervention, monthly post-intervention, and 6-months post-intervention. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Frontolimbic neural circuit activation and connectivity
Suicidality
Secondary outcome measures
Markers of negative affectivity
Mood and psychiatric symptoms

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Crisis Response Planning (CRP)Experimental Treatment1 Intervention
The crisis response planning (CRP) session will last between 30 minutes to 1-hour. It will occur face-to-face with a trained study therapist. The CRP session involves the following standard suicide intervention strategies: supportive listening, provision of crisis resources, and referral to a mental health professional (if not already established). The CRP active component involves a collaborative process in which the therapist invites the patient to share the events, symptoms, and contextual factors leading up to and surrounding the participant's suicidal crisis. Next, the patient and therapist identify the patient's personal warning signs for an emotional crisis, self-management coping skills, patient's reasons for living, and sources of social support. These components are written, by the patient, on an index card. The index card serves as a concrete reference for patients in the real-world.
Group II: ControlActive Control1 Intervention
Individuals who have not experienced suicidal ideation will not complete a suicide intervention.
Group III: Crisis Risk CounselingActive Control1 Intervention
The crisis risk counseling session will last between 30 minutes to 1-hour. It will occur face-to-face with a trained study therapist. It will include the following standard suicide intervention strategies: supportive listening, provision of crisis resources, and referral to a mental health professional (if not already established). The therapist will conduct a semi-structured suicide risk assessment interview, after which subjects will complete a self-guided safety plan worksheet. The worksheet takes approximately 10-minutes to complete and will be done independently.

Find a Location

Who is running the clinical trial?

Ohio State UniversityLead Sponsor
829 Previous Clinical Trials
505,445 Total Patients Enrolled
18 Trials studying Suicide
42,012 Patients Enrolled for Suicide
Stephanie Gorka, PhDPrincipal InvestigatorOhio State University

Media Library

Crisis Response Planning Clinical Trial Eligibility Overview. Trial Name: NCT05275101 — N/A
Suicide Research Study Groups: Control, Crisis Response Planning (CRP), Crisis Risk Counseling
Suicide Clinical Trial 2023: Crisis Response Planning Highlights & Side Effects. Trial Name: NCT05275101 — N/A
Crisis Response Planning 2023 Treatment Timeline for Medical Study. Trial Name: NCT05275101 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are any slots still accessible for individuals to join this experiment?

"Affirmative. Clinicaltrials.gov displays that this investigation, first advertised on July 28th 2021, is recruiting applicants at present. A total of 190 patients need to be mustered from a single medical facility."

Answered by AI

How many participants have been admitted to this experiment?

"Affirmative. Clinicaltrials.gov provides evidence that this clinical trial, initially posted on July 28th 2021, is still recruiting individuals for the study. A total of 190 patients are sought from a single medical site to take part in the research project."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Neural Mechanisms and Predictors of an Ultra-Brief Suicide Prevention Strategy
Stephanie M Gorka, PhD 2021. "Neural Mechanisms and Predictors of an Ultra-Brief Suicide Prevention Strategy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05275101.
~59 spots leftby Aug 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top